Marc Engelhardt

Chief Medical Officer at Basilea Pharmaceutica AG

Marc Engelhardt

Marc Engelhardt

Chief Medical Officer at Basilea Pharmaceutica AG

Biography

Marc Engelhardt is Chief Medical Officer at Basilea Pharmaceutica AG. Dr. Engelhardt previously was Director-Global Program Medical at Novartis Pharma AG. Dr. Engelhardt received a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main.

Overview
RelSci Relationships

129

Number of Boards

1

Birthday

1964

Age

57

Relationships
RelSci Relationships are individuals Marc Engelhardt likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Basilea Pharmaceutica AG

Relationship likelihood: Strong

Chief Financial Officer at Basilea Pharmaceutica AG

Relationship likelihood: Strong

Former Chief Executive Officer at Basilea Pharmaceutica AG

Relationship likelihood: Strong

General Counsel & Corporate Secretary at Basilea Pharmaceutica AG

Relationship likelihood: Strong

Chief Technology Officer at Basilea Pharmaceutica AG

Relationship likelihood: Strong

Chief Scientific Officer at Basilea Pharmaceutica AG

Relationship likelihood: Strong

Head of Global Human Resources at Basilea Pharmaceutica AG

Relationship likelihood: Strong

Head of Global Quality Management at Basilea Pharmaceutica AG

Relationship likelihood: Strong

Senior Vice President & Chief Financial Officer at Hansa Biopharma AB

Relationship likelihood: Strong

Chief Technology Officer at Union Therapeutics A/S

Relationship likelihood: Strong

Paths to Marc Engelhardt
Potential Connections via
Relationship Science
You
Marc Engelhardt
Chief Medical Officer at Basilea Pharmaceutica AG
Education

The Goethe University Frankfurt (full German name: Johann Wolfgang Goethe-Universität Frankfurt am Main) is a university which was founded in 1914 as a Citizens' University, which means that, while it was a State university of Prussia, it had been founded and financed by the wealthy and active liberal citizenry of Frankfurt am Main, a unique feature in German university history. It was named in 1932 after one of the most famous natives of Frankfurt, the poet and writer Johann Wolfgang von Goethe. Today, the university has 38,000 students, on 4 major campuses. Until now Goethe University Frankfurt has produced 14 Nobel Prize winners, including 8 graduates.Being research focused, the university is an affiliate of 11 academics, who have been awarded the Gottfried Wilhelm Leibniz Prize, the highest research prize in Germany.

Career History
Chief Medical Officer
2018 - Current

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX:BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.

Director-Global Program Medical
Prior

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Other Affiliations

Marc Engelhardt is affiliated with Basilea Pharmaceutica AG, Novartis Pharma AG

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Marc Engelhardt. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Marc Engelhardt's profile does not indicate a business or promotional relationship of any kind between RelSci and Marc Engelhardt.